Breaking News Instant updates and real-time market news.

T

AT&T

$42.42

-0.19 (-0.45%)

, IBM

IBM

$175.70

0.05 (0.03%)

05:36
03/21/17
03/21
05:36
03/21/17
05:36

AT&T introduces new IoT analytics solution powered by IBM Watson

AT&T (T) and IBM (IBM) unveiled a new way for companies to unlock more value from their data in a simpler way, using AT&T's IoT solutions and IBM Cloud. The new AT&T IoT analytics capability, a pilot collaboration between the two companies, aims to help AT&T's enterprise customers transform their industrial IoT data into analytic insights so they can take immediate action to improve business operations. The demand for near real-time operations data is fueling the IoT explosion among business customers. The key for business customers, however, is not just collecting the data from their connected assets, but extracting meaningful insights from it and then making near real-time decisions. With this new service, companies can utilize their own generated IoT data to better predict maintenance and optimization for their machines. For example, an oil and gas company wants to detect anomalous events within its wells. By using AT&T's IoT network and the IBM Watson Data Platform, AT&T's IoT analytics solutions will ingest data from hundreds of wells, creating the models necessary with appropriate machine learning libraries and open-source technology to help predict potential failures or machine malfunctions. The company will be able to detect anomalies in less time and with more accuracy.

T

AT&T

$42.42

-0.19 (-0.45%)

IBM

IBM

$175.70

0.05 (0.03%)

  • 21

    Mar

  • 28

    Mar

  • 09

    May

T AT&T
$42.42

-0.19 (-0.45%)

03/08/17
WELS
03/08/17
NO CHANGE
WELS
Tower sector upgraded to Overweight at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche upgraded the Tower sector to Overweight from Market Weight saying it is time to get off the sidelines. Tower companies are positioned to benefit from additional spend from AT&T (T) related to FirstNet, Fritzsche tells investors in a research note. In conjunction with the sector, the analyst upgraded Crown Castle (CCI) to Outperform from Market Perform, and calls the stock her new top pick in the space. The analyst also has an Outperform rating on Uniti Group (UNIT).
03/08/17
WELS
03/08/17
UPGRADE
WELS
Outperform
Crown Castle upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jennifer Fritzsche upgraded Crown Castle (CCI) to Outperform saying the company is poised to benefit from an increase in carrier activity before the other public tower companies given its large exposure to AT&T (T) and domestic focus. The analyst raised her price target range for the shares to $110-$115 from $98-$100 and calls Crown Castle her top pick in the towers group.
03/06/17
UBSW
03/06/17
DOWNGRADE
Target $108
UBSW
Neutral
Time Warner downgraded to Neutral from Buy at UBS
UBS analyst Doug Mitchelson downgraded Time Warner (TWX) to Neutral citing limited upside potential given the terms of the AT&T (T) offer. Time Warner shares now trade at a less than 10% spread to the AT&T offer value, the analyst notes. He keeps a $108 price target for the shares.
03/02/17
LOOP
03/02/17
DOWNGRADE
Target $107.5
LOOP
Hold
Time Warner downgraded to Hold from Buy at Loop Capital
Loop Capital analyst David Miller downgraded Time Warner (TWX) to Hold saying the AT&T (T) deal spread is "finally thinning." The analyst keeps a $107.50 price target for the shares.
IBM IBM
$175.70

0.05 (0.03%)

03/16/17
MSCO
03/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM target raised to $212 on 'undervalued' cloud opportunity at Morgan Stanley
Morgan Stanley analyst Katy Huberty said IBM's cloud opportunity remains underappreciated as she expects its $3B Public Cloud business to grow in line with the market at a 33% CAGR from 2016-20 with its gross and operating margins expanding to industry average by the end of that period. Huberty raised her price target on IBM shares to $212 from $187 and keeps an Overweight rating on the stock.
03/07/17
PIPR
03/07/17
NO CHANGE
Target $100
PIPR
Overweight
IBM deal achieves Salesforce Service Cloud deployment goal, says Piper Jaffray
Piper Jaffray analyst Alex Zukin said the artificial intelligence deal announced last night with IBM (IBM) is important for Salesforce (CRM) as it achieves the company goal of getting a traditional large competitor to deploy Service Cloud and because it could lead to other future strategic transactions. The analyst also noted Salesforce CEO Marc Benioff used the occasion to offer an "interesting...bit of color" that he doesn't see any acquisitions in the short-term, while pointing out that M&A and slowing growth were recurring investor concerns last year. Zukin, who continues to see Salesforce having the ability to get to $20B in revenue, keeps an Overweight rating and $100 price target on the stock.
02/23/17
RAJA
02/23/17
NO CHANGE
RAJA
Strong Buy
NVIDIA the 'acceleration supplier of choice' for cloud/HPC, says Raymond James
After meeting with representatives from IBM (IBM) and Kinetic, Raymond James analyst J. Steven Smigie said he came away with the impression that NVIDIA (NVDA) remains the "acceleration supplier of choice for alternative cloud/HPC solutions" versus Intel (INTC) and that adoption for GPU-accelerated enterprise and database management applications is "still in the earliest innings." He maintains a Strong Buy rating on NVIDIA, which was just downgraded to Underperform at BMO Capital and to Reduce at Nomura.
02/23/17
BOFA
02/23/17
NO CHANGE
Target $200
BOFA
Buy
IBM price target raised to $200 from $185 at BofA/Merrill

TODAY'S FREE FLY STORIES

06:05
05/29/17
05/29
06:05
05/29/17
06:05
General news
WTI crude futures are off by 0.2% »

WTI crude futures are off…

03:10
05/29/17
05/29
03:10
05/29/17
03:10
General news
FX Update: The dollar majors have been plying narrow ranges »

FX Update: The dollar…

03:05
05/29/17
05/29
03:05
05/29/17
03:05
General news
Fed's Williams: three hikes this year still make sense. »

Fed's Williams:…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

, MJN

Mead Johnson

$89.29

0.1 (0.11%)

15:32
05/28/17
05/28
15:32
05/28/17
15:32
Conference/Events
Mead Johnson to host special shareholder meeting »

Special Shareholder…

RBGLY

Reckitt Benckiser

$20.53

0.04 (0.20%)

MJN

Mead Johnson

$89.29

0.1 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

PHH

PHH Corp.

$13.58

0.06 (0.44%)

15:25
05/28/17
05/28
15:25
05/28/17
15:25
Conference/Events
PHH Corp. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

TPIV

TapImmune

$3.71

-0.03 (-0.80%)

14:37
05/28/17
05/28
14:37
05/28/17
14:37
Conference/Events
TapImmune to hold a business update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SCOR

comScore

$24.80

-0.15 (-0.60%)

14:35
05/28/17
05/28
14:35
05/28/17
14:35
Conference/Events
comScore to host business news update conference call »

Management holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

BMY

Bristol-Myers

$53.97

-0.42 (-0.77%)

14:12
05/28/17
05/28
14:12
05/28/17
14:12
Conference/Events
Bristol-Myers to hold a pharmaceutical update conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

  • 24

    Sep

LOXO

Loxo Oncology

$47.44

-0.06 (-0.13%)

14:10
05/28/17
05/28
14:10
05/28/17
14:10
Conference/Events
Loxo Oncology to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 04

    Jun

  • 06

    Jun

ADRO

Aduro Biotech

$10.05

-0.15 (-1.47%)

14:07
05/28/17
05/28
14:07
05/28/17
14:07
Conference/Events
Aduro Biotech to host analyst and investor meeting »

Management hosts special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

ELGX

Endologix

$4.73

-0.05 (-1.05%)

14:06
05/28/17
05/28
14:06
05/28/17
14:06
Conference/Events
Endologix to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 03

    Jun

TSRO

Tesaro

$149.11

-4.08 (-2.66%)

14:02
05/28/17
05/28
14:02
05/28/17
14:02
Conference/Events
Tesaro to hold an analyst and investor briefing »

Management hosts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 03

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$60.35

-0.09 (-0.15%)

13:57
05/28/17
05/28
13:57
05/28/17
13:57
Conference/Events
IntercontinentalExchange to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 07

    Jun

CPA

Copa Holdings

$111.69

0.2 (0.18%)

13:48
05/28/17
05/28
13:48
05/28/17
13:48
Conference/Events
Copa Holdings to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

CAH

Cardinal Health

$73.10

-0.34 (-0.46%)

13:31
05/28/17
05/28
13:31
05/28/17
13:31
Conference/Events
Cardinal Health to hold a meeting »

Dublin Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

BPMX

BioPharmX

$0.64

0.0089 (1.41%)

13:26
05/28/17
05/28
13:26
05/28/17
13:26
Conference/Events
BioPharmX holds state of acne symposium »

Management provides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$80.63

-0.72 (-0.89%)

13:20
05/28/17
05/28
13:20
05/28/17
13:20
Conference/Events
Novartis to hold a meeting »

Meet the Management Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 26

    Jun

CNC

Centene

$74.57

-0.68 (-0.90%)

, MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

12:34
05/27/17
05/27
12:34
05/27/17
12:34
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$74.57

-0.68 (-0.90%)

MOH

Molina Healthcare

$66.87

-0.21 (-0.31%)

HUM

Humana

$232.25

0.02 (0.01%)

AET

Aetna

$145.57

0.34 (0.23%)

ANTM

Anthem

$183.08

1.58 (0.87%)

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

WCG

WellCare

$172.97

0.15 (0.09%)

CI

Cigna

$161.32

-0.33 (-0.20%)

BX

Blackstone

$32.58

0.11 (0.34%)

NUE

Nucor

$58.15

-0.22 (-0.38%)

X

U.S. Steel

$19.74

-0.51 (-2.52%)

STLD

Steel Dynamics

$33.71

-0.73 (-2.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 13

    Jun

  • 16

    Jun

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.